Nurix Therapeutics (NRIX) Earnings Date, Estimates & Call Transcripts $11.04 -0.22 (-1.95%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$11.04 0.00 (0.00%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nurix Therapeutics Earnings Summary Nurix Therapeutics issued Q2 2025 earnings on July 9, 2025, reporting an EPS of -$0.52, which beat analysts' consensus estimates of -$0.79 by $0.27. Quarterly revenue was reported to be $44,056 billion, above analyst estimates of $16.26 million. With a trailing EPS of -$2.61, Nurix Therapeutics' earnings are expected to decrease next year, from ($2.99) to ($3.01) per share. Upcoming Q3 Earnings DateOct. 10EstimatedConsensus EPS (Jul. 9) -$0.79 Actual EPS (Jul. 9) -$0.52 Beat By $0.27 Actual Revenue (Jul. 9) $44,056.00BQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)NRIX Upcoming EarningsNurix Therapeutics' next earnings date is estimated for Friday, October 10, 2025, based on past reporting schedules. Powered by Get Nurix Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nurix Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNRIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRIX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Nurix Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.89-$0.60-$0.75Q2 20252-$0.84-$0.62-$0.73Q3 20252-$0.96-$0.68-$0.82Q4 20252-$0.99-$0.89-$0.94 FY 2025 8 -$3.68 -$2.79 -$3.24 Q1 20262-$1.03-$0.91-$0.97Q2 20262-$1.09-$0.94-$1.02Q3 20262-$1.15-$0.97-$1.06Q4 20262-$1.01-$0.91-$0.96 Nurix Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/10/2025(Estimated)--------7/9/2025Q2 2025-$0.79-$0.52+$0.27-$0.52$16.26M$44,056.00B4/8/2025Q1 2025-$0.72-$0.67+$0.05-$0.67$12.78M$18.45M1/28/2025Q4 2024-$0.67-$0.75 -$0.08-$0.75--10/11/2024--$0.67-$0.67--$0.67$13.85M$12.59M7/11/2024Q2 2024-$0.63-$0.71 -$0.08-$0.71$19.35M$12.09M4/10/2024Q1 2024-$0.80-$0.76+$0.04-$0.76$14.58M$16.59M2/15/2024Q4 2023-$0.51-$0.77 -$0.26-$0.77$30.66M$15.16M10/12/2023Q3 2023-$0.84-$0.68+$0.16-$0.68$19.98M$18.47M Nurix Therapeutics Earnings - Frequently Asked Questions When is Nurix Therapeutics' earnings date? Nurix Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 10th, 2025 based off last year's report dates. Learn more on NRIX's earnings history. Did Nurix Therapeutics beat their earnings estimates last quarter? In the previous quarter, Nurix Therapeutics (NASDAQ:NRIX) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.27. Learn more on analysts' earnings estimate vs. NRIX's actual earnings. How much revenue does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded annual revenue of $54.55 million. How much profit does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded net income of -$193.57 million. NRIX has generated -$2.61 earnings per share over the last four quarters. What is Nurix Therapeutics' EPS forecast for next year? Nurix Therapeutics' earnings are expected to decrease from ($2.99) per share to ($3.01) per share in the next year. More Earnings Resources from MarketBeat Related Companies Protagonist Therapeutics Earnings Date Kymera Therapeutics Earnings Date Crinetics Pharmaceuticals Earnings Date Immunovant Earnings Date Alvotech Earnings Date Organon & Co. Earnings Date NewAmsterdam Pharma Earnings Date Recursion Pharmaceuticals Earnings Date Ultragenyx Pharmaceutical Earnings Date Mirum Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:NRIX) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRIX Stock Alerts